Eir Partners Acquires Controlling Stake in QuartzBio
May 13, 2026
Eir Partners acquired a controlling interest in QuartzBio, a life science technology company providing connected sample and biomarker intelligence for clinical-stage biopharma. The growth investment is intended to help QuartzBio expand its biomarker intelligence offerings and scale operations, while accelerating platform enhancements such as AI-driven automation, interoperability, and enterprise scalability.
- Buyers
- Eir Partners
- Targets
- QuartzBio
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.